143 related articles for article (PubMed ID: 34524226)
21. MED15, transforming growth factor beta 1 (TGF-β1), FcγRIII (CD16), and HNK-1 (CD57) are prognostic biomarkers of oral squamous cell carcinoma.
Elahi M; Rakhshan V
Sci Rep; 2020 May; 10(1):8475. PubMed ID: 32439976
[TBL] [Abstract][Full Text] [Related]
22. Hsa_circ_0086414 Might Be a Diagnostic Biomarker of Oral Squamous Cell Carcinoma.
Li L; Zhang ZT
Med Sci Monit; 2020 Jan; 26():e919383. PubMed ID: 31933490
[TBL] [Abstract][Full Text] [Related]
23. Nano-bio-chip sensor platform for examination of oral exfoliative cytology.
Weigum SE; Floriano PN; Redding SW; Yeh CK; Westbrook SD; McGuff HS; Lin A; Miller FR; Villarreal F; Rowan SD; Vigneswaran N; Williams MD; McDevitt JT
Cancer Prev Res (Phila); 2010 Apr; 3(4):518-28. PubMed ID: 20332305
[TBL] [Abstract][Full Text] [Related]
24. Promoter hypermethylation and silencing of tissue factor pathway inhibitor-2 in oral squamous cell carcinoma.
Lai YH; He RY; Chou JL; Chan MW; Li YF; Tai CK
J Transl Med; 2014 Sep; 12():237. PubMed ID: 25179542
[TBL] [Abstract][Full Text] [Related]
25. Liquid biopsy: miRNA as a potential biomarker in oral cancer.
Mazumder S; Datta S; Ray JG; Chaudhuri K; Chatterjee R
Cancer Epidemiol; 2019 Feb; 58():137-145. PubMed ID: 30579238
[TBL] [Abstract][Full Text] [Related]
26. Genomic profiling of advanced-stage oral cancers reveals chromosome 11q alterations as markers of poor clinical outcome.
Ambatipudi S; Gerstung M; Gowda R; Pai P; Borges AM; Schäffer AA; Beerenwinkel N; Mahimkar MB
PLoS One; 2011 Feb; 6(2):e17250. PubMed ID: 21386901
[TBL] [Abstract][Full Text] [Related]
27. Non-coding RNAs deregulation in oral squamous cell carcinoma: advances and challenges.
Yu T; Li C; Wang Z; Liu K; Xu C; Yang Q; Tang Y; Wu Y
Clin Transl Oncol; 2016 May; 18(5):427-36. PubMed ID: 26370423
[TBL] [Abstract][Full Text] [Related]
28. Novel technologies for oral squamous carcinoma biomarkers in diagnostics and prognostics.
Irimie AI; Braicu C; Cojocneanu-Petric R; Berindan-Neagoe I; Campian RS
Acta Odontol Scand; 2015 Apr; 73(3):161-8. PubMed ID: 25598447
[TBL] [Abstract][Full Text] [Related]
29. Genetic and Epigenetic Biomarkers of Molecular Alterations in Oral Carcinogenesis.
Dumache R; Rogobete AF; Andreescu N; Puiu M
Clin Lab; 2015; 61(10):1373-81. PubMed ID: 26642697
[TBL] [Abstract][Full Text] [Related]
30. circMAN1A2 could serve as a novel serum biomarker for malignant tumors.
Fan CM; Wang JP; Tang YY; Zhao J; He SY; Xiong F; Guo C; Xiang B; Zhou M; Li XL; Li Y; Li GY; Xiong W; Zeng ZY
Cancer Sci; 2019 Jul; 110(7):2180-2188. PubMed ID: 31046163
[TBL] [Abstract][Full Text] [Related]
31. A Three Long Noncoding RNA-Based Signature for Oral Squamous Cell Carcinoma Prognosis Prediction.
Zhao C; Zou H; Wang J; Shen J; Liu H
DNA Cell Biol; 2018 Nov; 37(11):888-895. PubMed ID: 30234381
[TBL] [Abstract][Full Text] [Related]
32. Contemporary management of cancer of the oral cavity.
Genden EM; Ferlito A; Silver CE; Takes RP; Suárez C; Owen RP; Haigentz M; Stoeckli SJ; Shaha AR; Rapidis AD; Rodrigo JP; Rinaldo A
Eur Arch Otorhinolaryngol; 2010 Jul; 267(7):1001-17. PubMed ID: 20155361
[TBL] [Abstract][Full Text] [Related]
33. Tumour-infiltrating T-cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature review.
Nosho K; Baba Y; Tanaka N; Shima K; Hayashi M; Meyerhardt JA; Giovannucci E; Dranoff G; Fuchs CS; Ogino S
J Pathol; 2010 Dec; 222(4):350-66. PubMed ID: 20927778
[TBL] [Abstract][Full Text] [Related]
34. [CD45RO⁺ Memory T Lymphocytes As A Candidate Marker for Non-small Cell Lung Cancer].
Tan Q; Li H; Yu M; Tang X; Tan J; Zhang S; Wang J
Zhongguo Fei Ai Za Zhi; 2021 Apr; 24(4):254-264. PubMed ID: 33910273
[TBL] [Abstract][Full Text] [Related]
35. Prognostic markers for oral cancer: An overview of the current status and directions for future research.
de Oliveira LQR; Almangush A; Al-Samadi A; Salo T; Coletta RD
J Oral Pathol Med; 2023 Apr; 52(4):288-293. PubMed ID: 36659864
[TBL] [Abstract][Full Text] [Related]
36. Identification and validation of potential novel biomarkers for oral squamous cell carcinoma.
Zhang M; Chen X; Chen H; Zhou M; Liu Y; Hou Y; Nie M; Liu X
Bioengineered; 2021 Dec; 12(1):8845-8862. PubMed ID: 34606406
[TBL] [Abstract][Full Text] [Related]
37. Polymorphisms and Plasma Levels of Tissue Inhibitor of Metalloproteinase-3: Impact on Genetic Susceptibility and Clinical Outcome of Oral Cancer.
Su CW; Huang YW; Chen MK; Su SC; Yang SF; Lin CW
Medicine (Baltimore); 2015 Nov; 94(46):e2092. PubMed ID: 26579821
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of Salivary Transcriptome Markers for the Early Detection of Oral Squamous Cell Cancer in a Prospective Blinded Trial.
Martin JL; Gottehrer N; Zalesin H; Hoff PT; Shaw M; Clarkson JH; Haan P; Vartanian M; McLeod T; Swanick SM
Compend Contin Educ Dent; 2015 May; 36(5):365-73. PubMed ID: 26053640
[TBL] [Abstract][Full Text] [Related]
39. Salivary transcriptome diagnostics for oral cancer detection.
Li Y; St John MA; Zhou X; Kim Y; Sinha U; Jordan RC; Eisele D; Abemayor E; Elashoff D; Park NH; Wong DT
Clin Cancer Res; 2004 Dec; 10(24):8442-50. PubMed ID: 15623624
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic and therapeutic role of microRNAs in oral cancer (Review).
Wang J; Lv N; Lu X; Yuan R; Chen Z; Yu J
Oncol Rep; 2021 Jan; 45(1):58-64. PubMed ID: 33200230
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
